financetom
Business
financetom
/
Business
/
Omega Healthcare Investors Q2 Adjusted FFO Declines, Revenue Rises; 2024 AFFO Guidance Raised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Omega Healthcare Investors Q2 Adjusted FFO Declines, Revenue Rises; 2024 AFFO Guidance Raised
Aug 1, 2024 3:16 PM

05:57 PM EDT, 08/01/2024 (MT Newswires) -- Omega Healthcare Investors ( OHI ) reported Q2 adjusted funds from operations late Thursday of $0.71 per share, down from $0.74 a year earlier.

Analysts polled by Capital IQ expected $0.65.

Revenue for the quarter ended June 30 was $252.7 million, up from $250.2 million a year earlier. Analysts surveyed by Capital IQ expected $207 million.

The company raised its full-year 2024 adjusted FFO guidance to between $2.78 and $2.84 per diluted share from $2.70 and $2.80.

Shares of Omega Healthcare were down 1.6% in after-hours activity.

Price: 36.10, Change: -0.60, Percent Change: -1.63

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Patagonia Gold Increased Loan Facility
Patagonia Gold Increased Loan Facility
Jul 26, 2024
05:05 PM EDT, 07/26/2024 (MT Newswires) -- Patagonia Gold Corp. ( HGLD ) said after trade Friday it entered into an agreement with Cantomi Uruguay S.A. to increase the maximum aggregate amount of the Cantomi Loan. According to a statement, the original loan facility, which Cantomi provided in February 2019 for US$15 million was subsequently amended and further increased to...
vTv Therapeutics' Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold; Shares Sink
vTv Therapeutics' Cadisegliatin Program for Type 1 Diabetes Placed on Clinical Hold; Shares Sink
Jul 26, 2024
05:04 PM EDT, 07/26/2024 (MT Newswires) -- vTv Therapeutics ( VTVT ) said late Friday the US Food and Drug Administration has placed a clinical hold on its cadisegliatin clinical program, including an ongoing CATT1 phase 3 trial in type 1 diabetes. The clinical hold was based on the discovery of a chromatographic signal in a recent human absorption, distribution,...
--Warrior Met Coal Maintains Quarterly Dividend at $0.08 a Share, Payable Aug. 13 to Holders as of Aug. 6
--Warrior Met Coal Maintains Quarterly Dividend at $0.08 a Share, Payable Aug. 13 to Holders as of Aug. 6
Jul 26, 2024
04:13 PM EDT, 07/26/2024 (MT Newswires) -- Price: 69.47, Change: -0.01, Percent Change: -0.02 ...
Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
Premier American Uranium Outlines Multiple Targets for Expansion Drilling at the Cebolleta Project, New Mexico
Jul 26, 2024
05:09 PM EDT, 07/26/2024 (MT Newswires) -- Premier American Uranium Inc. ( PAUIF ) , which rose 2.5% today, after trade Friday outlined targets as part of its exploration growth plans at the company's flagship Cebolleta Project located in the Grants Mineral Belt in New Mexico. A statement noted uranium mineralization at PUR's Cebolleta project are the northern extension of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved